PCA3 and prostate cancer: In our quest to elucidate the mechanisms for docetaxel resistance in prostate cancer, we initiated our analysis by examining the RNA expression profiles of three prostate cancer organoids—namely, MSK-PCa3, MSK-PCa7, and PM154.